Status:
COMPLETED
COVID-19 Glycemic Control Study
Lead Sponsor:
Leiden University Medical Center
Conditions:
Type 1 Diabetes
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Diabetes mellitus is a chronic disease characterized by the inability of the body to maintain normoglycemia. Treatment of diabetes relies mostly on diabetes self-management, requiring a large investme...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosed with type 1 or type 2 diabetes
- Ability to perform fingerpricks
- Sufficient comprehension of the Dutch language
- Ability to fill out online questionnaires
Exclusion
- Pregnancy
- Newly diagnosed malignancy, with the exclusion of non-melanoma skin cancer, in the previous 6 months
- Chemotherapy or immunotherapy for malignancy
- Admission to hospital or rehabilitation center
Key Trial Info
Start Date :
May 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2020
Estimated Enrollment :
492 Patients enrolled
Trial Details
Trial ID
NCT05977205
Start Date
May 2 2020
End Date
July 10 2020
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333 ZA